Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khaldoun Almhanna

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Targeted therapy for gastric adenocarcinomaKhaldoun Almhanna
Journal of Surgical Case Reports|September 27, 2018
Large rib osteochondroma in a child in Aleppo, SyriaSamer Alhames, Khaldoun Almhanna
Translational Gastroenterology and Hepatology|March 20, 2020
Esophageal, gastric cancer and immunotherapy: small steps in the right direction?Adam Zayac, Khaldoun Almhanna
Annals of Translational Medicine|November 4, 2020
Locoregional gastric cancer: a narrative review of multidisciplinary managementAri Pelcovits, Khaldoun Almhanna
Oncology (Williston Park, N.Y.)|October 22, 2008
Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a standard?Khaldoun Almhanna, Richard Kim
Translational Gastroenterology and Hepatology|March 20, 2020
Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?Adam Zayac, Khaldoun Almhanna
Journal of Gastrointestinal Oncology|February 3, 2015
Current status of novel agents in advanced gastroesophageal adenocarcinomaNishi Kothari, Khaldoun Almhanna
Oncotargets and Therapy|July 10, 2010
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinomaKhaldoun Almhanna, Philip A Philip
Cancers|September 10, 2021
Beyond Chemotherapy, PD-1, and HER-2: Novel Targets for Gastric and Esophageal CancerAli Zubair Siddiqui, Khaldoun Almhanna
World Journal of Gastroenterology|November 17, 2012
Multimodality approach for locally advanced esophageal cancerKhaldoun Almhanna, Jonathan R Strosberg
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Advances in Pharmacology (San Diego, Calif.)|September 11, 2012
Targeted therapy for gastric adenocarcinomaKhaldoun Almhanna
Journal of Surgical Case Reports|September 27, 2018
Large rib osteochondroma in a child in Aleppo, SyriaSamer Alhames, Khaldoun Almhanna
Translational Gastroenterology and Hepatology|March 20, 2020
Esophageal, gastric cancer and immunotherapy: small steps in the right direction?Adam Zayac, Khaldoun Almhanna
Annals of Translational Medicine|November 4, 2020
Locoregional gastric cancer: a narrative review of multidisciplinary managementAri Pelcovits, Khaldoun Almhanna
Oncology (Williston Park, N.Y.)|October 22, 2008
Second-line therapy for gemcitabine-refractory pancreatic cancer: is there a standard?Khaldoun Almhanna, Richard Kim
Translational Gastroenterology and Hepatology|March 20, 2020
Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?Adam Zayac, Khaldoun Almhanna
Journal of Gastrointestinal Oncology|February 3, 2015
Current status of novel agents in advanced gastroesophageal adenocarcinomaNishi Kothari, Khaldoun Almhanna
Oncotargets and Therapy|July 10, 2010
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinomaKhaldoun Almhanna, Philip A Philip
Cancers|September 10, 2021
Beyond Chemotherapy, PD-1, and HER-2: Novel Targets for Gastric and Esophageal CancerAli Zubair Siddiqui, Khaldoun Almhanna
World Journal of Gastroenterology|November 17, 2012
Multimodality approach for locally advanced esophageal cancerKhaldoun Almhanna, Jonathan R Strosberg
Pageof 11